Abstract 4370057: Comparison of non-calcified to calcified plaque ratio versus noncalcified plaque burden to predict adverse cardiovascular outcomes in the CONFIRM2 registry
Abstract
Background: While the burden and morphological features of coronary atherosclerosis are both important drivers of major adverse cardiovascular events (MACE), there remains uncertainty about which plaque type is more likely to predispose to MACE i.e. noncalcified plaque (NCP) or calcified plaque (CP). Research question: Does NCP:CP ratio or NCP volume influence MACE in patients from the CONFIRM2 registry, an international, observational cohort study? Methods: Symptomatic patients without prior MI/revascularization referred to coronary CTA for clinical indications were included. CP and NCP volumes were determined using artificial intelligence-facilitated coronary CT (AI-QCT). The primary endpoint (MACE) was a composite of all-cause death, myocardial infarction, stroke, heart failure, late revascularization, and hospitalization for unstable angina. Results: Of the 3,551 patients (median age 59 years; 49.5% women), data were available for 3,301. A total of 250 patients with no identifiable plaque were excluded from the analysis. MACE occurred in 4.7% of patients (median f/u 51 months). Hypertension, hyperlipidemia, and smoking were present in 54.3%, 48.1%, and 14%. Statin use in 67.3%, CACS = 0 in 41.7%. 91% had NCP <250 mm 3 , 8.4% 250-750 mm 3 and 0.7% >750 mm 3 . MACE rates for tertiles of NCP:CP ratio were statistically significant (Panel A; p=0.0003): 1 st tertile (Mean NCP:CP ratio of 46%; n=1100 patients; median NCP volume = 85.6 mm 3 ; MACE rate of 5.6%); 2 nd tertile (NCP:CP 81%; n=1101; NCPvol. = 67.6 mm 3 ; 6.6%); 3 rd tertile (NCP:CP 99%; n=1100; NCPvol. = 22.3 mm 3 ; 2.9%). However, in a multivariable Cox proportional hazards model adjusted for sex and age, when adjusting also for NCP volume, the NCP:CP tertile ratio did not remain a significant predictor of MACE, p=0.115 (Model#3, Panel B). Only 9 patients had predominant CP (NCP:CP ratio<10%) while the majority had predominant NCP. Conclusions: The main driver of incident MACE was the noncalcified plaque volume (NCP) rather than the NCP:CP ratio. More data with a larger cohort of patients with relatively more CP is needed to evaluate the role of individual features of partially calcified plaques such as spotty calcification to assess if they are better predictors of MACE or whether NCP volume alone is sufficient.
Article Details
Authors (47)
Dinesh Kalra
University of Louisville, Louisville, Kentucky, United States
Alexander van Rosendael
Leiden University Medical Center, Leiden, Netherlands
Jisuk Park
Cleerly, Inc., Durham, North Carolina, United States
Andrew Oehler
Allegheny Health Network, Pittsburgh, Pennsylvania, United States
Jeroen Bax
Leiden University Medical Center, Leiden, Netherlands
Matthew Budoff
The Lundquist Institute, Torrance, California, United States
Himanshu Gupta
Maros Ferencik
George Wesbey
Scripps Clinic, La Jolla, California, United States
Nick Nurmohamed
Amsterdam UMC, Amsterdam, Netherlands
Rebecca Fisher
Christoph Gräni
Gudrun Feuchtner
Medical University Innsbruck, Innsbruck, Austria
Amro Alsaid
Baylor Scott and White - The Heart Hospitals, Plano, Texas, United States
Ronald Karlsberg
Cedars Sinai Heart Institute CVRF, Beverly Hills, California, United States
Ronny Buechel
University Hospital Zurich, Zurich, Switzerland
Vasileios Kamperidis
Aristotle University of Thessaloniki, Thessaloniki, Greece
Mirvat Alasnag
Daniele Andreini
CENTRO CARDIOLOGICO MONZINO, Milan, Italy
Sabha Bhatti
National Institute of Cardiovascular Diseases Karachi Pakistan, Karachi, Pakistan
Stephen Bloom
Midwest Heart and Vascular, Overland Park, Kansas, United States
Borek Foldyna
Kelley Branch
UNIVERSITY OF WASHINGTON, Seattle, Washington, United States
Filippo Cademartiri
IRCCS SYNLAB SDN, Naples, Italy
Rhanderson Cardoso
Brigham and Womens Hospital, Boston, Massachusetts, United States
Victor Cheng
Minneapolis Heart Institute, Minneapolis, Minnesota, United States
Geoffrey Cho
UCLA, Los Angeles, California, United States
Andrew Choi
The GW Medical Faculty Associates, Washiton, District of Columbia, United States
Carlo De Cecco
Emory University, Atlanta, Georgia, United States
Roderick Deano
University of Wisconsin, Madison, Wisconsin, United States
David German
OHSU, Portland, Oregon, United States
Martin Hadamitzky
Omar Khalique
St. Francis Hospital and Heart Center, Roslyn, New York, United States
Paul Knaapen
Amsterdam UMC, Amsterdam, Netherlands
Mouaz Al-Mallah
Houston Methodist DeBakey Heart&Vascular Center, Houston, Texas, United States
Jim Mills
West Virginia University, Morgantown, West Virginia, United States
Prashant Nagpal
University of Wisconsin-Madison, Madison, Wisconsin, United States
Rine Nakanishi
Toho University Medical Center, Tokyo, Japan
Gianluca Pontone
Amit Patel
Venkateshwar Polsani
Piedmont Heart Institute, Atlanta, Georgia, United States
Amit Pursnani
NorthShore, Chicago, Illinois, United States
Saima Mushtaq
Vasvi Singh
Midwest Heart and Vascular, Overland Park, Kansas, United States
Marly van Assen
Cristiane De Carvalho Singulane
University of Virginia, Charlottesville, Virginia, United States
Ibrahim Danad
Amsterdam UMC, Amsterdam, Netherlands